Skip to main content

Table 1 Sociodemographic and baseline characteristics (N = 67)

From: Fatigue in breast cancer patients on chemotherapy: a cross-sectional study exploring clinical, biological, and genetic factors

  Frequency (%)
Gender Female 67 (100%)
Nationality Lebanese 60 (89.6%)
Syrian 5 (7.5%)
Other 2 (3%)
Marital status Single 8 (11.9%)
Married 58 (86.6%)
Widowed 1 (1.5%)
Level of educationa Elementary 9 (13.8%)
Secondary 41 (63.1%)
University 15 (23.1%)
Profession/Work No 45 (67.2%)
Yes 22 (32.8.%)
  Mean ± Standard Deviation (SD)
Age (years) 56.22 ± 11.96
Body Mass Index (BMI; Kg/m2) 26.06 ± 3.79
Body Surface Area (BSA; m2) 1.76 ± 0.17
Pain VAS score 1.27 ± 2.08
Fatigue Score 42.12 ± 32.10
 ▪ Fatigue > 39 (clinically significant fatigue)b 31 (46.3%)
 ▪ Fatigue < 39 (no clinical fatigue)b 36 (56.7%)
Sleep evaluation
 Insomnia Severity Index (ISI) score 8.88 ± 6.35
 Pittsburgh Sleep Quality Index (PSQI) score 8.20 ± 4.33
Psychological factors
 HADS-A 7.18 ± 4.98
 HADS-D 6.67 ± 4.41
  1. aSome variables did not sum up to 67 due to missing data
  2. bThe score of 39 is the defined thresholds for clinical importance (TCIs) for the EORTC QLQ-C30 Computer Adaptive Testing Core measure [52, 53]